Tenet Reports Fourth Quarter and FY 2022 Results; Provides 2023 Financial Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Tenet Healthcare (THC) Tops Q4 EPS by 73c; Guides
February 9, 2023 6:58 AM ESTTenet Healthcare (NYSE: THC) reported Q4 EPS of $1.96, $0.73 better than the analyst estimate of $1.23. Revenue for the quarter came in at $4.99 billion versus the consensus estimate of $4.91 billion.
GUIDANCE:
Tenet Healthcare sees Q1 2023 EPS of $1.00-$1.23. Tenet Healthcare sees Q1... More
